Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.

PubWeight™: 1.78‹?› | Rank: Top 3%

🔗 View Article (PMID 9572495)

Published in Oncogene on April 23, 1998

Authors

J H Albrecht1, R Y Poon, C L Ahonen, B M Rieland, C Deng, G S Crary

Author Affiliations

1: Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA.

Articles citing this

Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. Hepatology (2015) 3.10

Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol (2002) 2.84

Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A (2004) 2.77

CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74

c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev (2006) 1.84

Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell (2008) 1.75

Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging. PLoS One (2015) 1.39

Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol (2003) 1.16

Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development (2009) 1.15

Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am J Pathol (2005) 1.14

Glycogen synthase kinase 3 β-dependent Snail degradation directs hepatocyte proliferation in normal liver regeneration. Proc Natl Acad Sci U S A (2011) 1.11

Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. Gastroenterology (2009) 1.06

Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle (2008) 1.03

Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice. Hepatology (2012) 1.00

p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology (2009) 0.99

Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo. Cell Cycle (2009) 0.97

Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control. J Biol Chem (2009) 0.97

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Am J Pathol (1999) 0.96

BMP4 is a novel paracrine inhibitor of liver regeneration. Am J Physiol Gastrointest Liver Physiol (2012) 0.95

A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One (2011) 0.94

Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene. Am J Pathol (2000) 0.93

Tob1 is a constitutively expressed repressor of liver regeneration. J Exp Med (2010) 0.92

Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line. World J Gastroenterol (2000) 0.92

Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res (2008) 0.92

Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration. Toxicol Sci (2014) 0.91

Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice. Hepatology (2011) 0.88

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression. Oncotarget (2016) 0.87

Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression. Mol Pharmacol (2014) 0.84

The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. Cancers (Basel) (2014) 0.82

Effects of heat shock on change of HSC70/HSP68, acid and alkaline phosphatases before and after rat partial hepatectomy. World J Gastroenterol (2000) 0.81

MiR-17~92 ablation impairs liver regeneration in an estrogen-dependent manner. J Cell Mol Med (2016) 0.80

Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells. Br J Cancer (2008) 0.80

Hepatocyte proliferation during liver regeneration is impaired in mice with methionine diet-induced hyperhomocysteinemia. Am J Pathol (2010) 0.80

Hepatic retinoid stores are required for normal liver regeneration. J Lipid Res (2013) 0.79

A novel role of proteasomal β1 subunit in tumorigenesis. Biosci Rep (2013) 0.79

Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. J Pharmacol Exp Ther (2014) 0.79

Induction of p53-dependent p21 limits proliferative activity of rat hepatocytes in the presence of hepatocyte growth factor. PLoS One (2013) 0.79

Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication. Int J Hepatol (2012) 0.79

Expression patterns of cytokine, growth factor and cell cycle-related genes after partial hepatectomy in rats with thioacetamide-induced cirrhosis. World J Gastroenterol (2006) 0.78

Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1). Dig Dis Sci (2006) 0.78

T160‐phosphorylated CDK2 defines threshold for HGF dependent proliferation in primary hepatocytes. Mol Syst Biol (2015) 0.77

Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. World J Gastroenterol (2008) 0.77

Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation. Oncotarget (2016) 0.75

T160-phosphorylated CDK2 defines threshold for HGF-dependent proliferation in primary hepatocytes. Mol Syst Biol (2015) 0.75

Histone Deacetylase SIRT1 Controls Proliferation, Circadian Rhythm, and Lipid Metabolism during Liver Regeneration in Mice. J Biol Chem (2016) 0.75

Partial hepatectomy in rats results in immediate down-regulation of p27Kip1 in residual liver tissue by transcriptional and post-translational processes. Front Physiol (2013) 0.75

Impaired liver regeneration is associated with reduced cyclin B1 in natural killer T cell-deficient mice. BMC Gastroenterol (2017) 0.75

Articles by these authors

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J (1999) 5.49

The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A (2000) 3.55

Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development (1998) 2.90

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem (2001) 2.85

The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A (1998) 2.51

The Saccharomyces cerevisiae kinesin-related motor Kar3p acts at preanaphase spindle poles to limit the number and length of cytoplasmic microtubules. J Cell Biol (1997) 2.33

Active anaphylaxis in IgE-deficient mice. Nature (1994) 2.32

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol (2000) 2.15

High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors. Mol Cell Biol (1992) 2.14

A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A (1999) 2.05

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature (1997) 2.03

A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest (1999) 1.96

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A (1999) 1.93

Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem (2000) 1.86

Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev (2000) 1.81

Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol (2001) 1.71

Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem (2000) 1.64

Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev (1995) 1.61

Post-transplant lymphoproliferative disease in children. Pediatr Transplant (2001) 1.51

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study. Eur J Neurol (2012) 1.45

p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. J Cell Biol (2000) 1.44

Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci U S A (1999) 1.42

Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature (1996) 1.41

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.41

Cdc37: a protein kinase chaperone? Trends Cell Biol (1997) 1.37

On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. Biochemistry (2000) 1.35

Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2. Mol Cell Biol (1999) 1.32

The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene (1995) 1.30

Animal models of myasthenia gravis. Clin Immunol (2000) 1.25

Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat (2003) 1.24

MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr Biol (1999) 1.24

A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum Mol Genet (2001) 1.23

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol (1999) 1.22

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J Exp Med (1997) 1.22

Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Cancer Res (1999) 1.19

MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins. Cancer Res (1999) 1.18

Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. J Immunol (1996) 1.17

Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J Clin Invest (2000) 1.15

Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence. J Immunol (2000) 1.14

Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood (1996) 1.13

Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem (2000) 1.13

MDM2 and MDMX can interact differently with ARF and members of the p53 family. FEBS Lett (2001) 1.10

Differential responses of proliferating versus quiescent cells to adriamycin. Exp Cell Res (1999) 1.07

Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis. Dev Biol (2001) 1.06

M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system. Receptors Channels (2003) 1.05

Light experience and lateralization of the two visual pathways in the chick. Behav Brain Res (1999) 1.05

Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl (2012) 1.04

Fibroblast growth factor receptors (FGFRs) and their roles in limb development. Cell Tissue Res (1999) 1.02

Cleavage of cyclin A at R70/R71 by the bacterial protease OmpT. Proc Natl Acad Sci U S A (2001) 1.00

Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol (1986) 0.98

Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis. Oncogene (2012) 0.97

A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Oncogene (2011) 0.96

Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene (2010) 0.96

Fibroblast growth factor receptor 4, implicated in progression of islet cell carcinogenesis by its expression profile, does not contribute functionally. Cell Growth Differ (1998) 0.96

Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration. Am J Physiol (1999) 0.93

Cyclin A and cyclin B dissociate from p34cdc2 with half-times of 4 and 15 h, respectively, regardless of the phase of the cell cycle. J Biol Chem (1994) 0.93

Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol Carcinog (1999) 0.92

Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome. Proc Natl Acad Sci U S A (1999) 0.92

A possible role of p73 on the modulation of p53 level through MDM2. Cancer Res (2001) 0.92

Modulation of obese gene expression in rat brown and white adipose tissues. FEBS Lett (1995) 0.91

Cyclin A recruits p33cdk2 to the cellular transcription factor DRTF1. J Cell Sci Suppl (1992) 0.90

Smad 3 may regulate follicular growth in the mouse ovary. Biol Reprod (2002) 0.90

Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol (1997) 0.89

Unexpected effects of a heterozygous dnmt1 null mutation on age-dependent DNA hypomethylation and autoimmunity. J Gerontol A Biol Sci Med Sci (2001) 0.89

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study. Neurology (2009) 0.88

G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells. FEBS Lett (1999) 0.88

The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J Immunol (1998) 0.87

Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas. Placenta (2013) 0.87

Motor deficits in fibroblast growth factor receptor-3 null mutant mice. Behav Pharmacol (2001) 0.85

Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience (2006) 0.85

Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. J Pharmacol Exp Ther (1998) 0.84

Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J Immunol (1997) 0.84

Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis. Oncogene (1997) 0.83

Role of nerve growth factor in experimental autoimmune encephalomyelitis. Eur J Immunol (2001) 0.82

Molecular phylogenetic diversity of bacteria and its spatial distribution in composts. J Appl Microbiol (2007) 0.82

Characterization of two monoclonal idiotype-binding suppressor T cell factors specific for the antibody response to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Immunol (1986) 0.81

Corticosterone treatment of the chick embryo affects light-stimulated development of the thalamofugal visual pathway. Behav Brain Res (2004) 0.81

A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion. J Thromb Haemost (2008) 0.81

[The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia]. Zhonghua Nei Ke Za Zhi (1999) 0.81

The spindle checkpoint in the dinoflagellate Crypthecodinium cohnii. Exp Cell Res (2000) 0.81

Antagonistic effects of Smad2 versus Smad7 are sensitive to their expression level during tooth development. J Biol Chem (2001) 0.80

Characterization of the cullin and F-box protein partner Skp1. FEBS Lett (1998) 0.80

The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis. Clin Immunol Immunopathol (1998) 0.79

Monoclonal antibody specific for human T acute lymphoblastic leukaemia. Lancet (1982) 0.79

Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance. J Neurol Neurosurg Psychiatry (2010) 0.79

Immunosuppressive effects of leflunomide in experimental chronic vascular rejection. Transplantation (1995) 0.79

Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers. Res Rep Health Eff Inst (2001) 0.79

The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain. Neuroscience (2009) 0.78

Cytotoxic monoclonal antibody to a human leiomyosacoma. Lancet (1981) 0.78

Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results. J Thromb Haemost (2012) 0.78

De novo immunotactoid glomerulopathy of the renal allograft: possible association with cytomegalovirus infection. Am J Kidney Dis (1994) 0.78

Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis. Eur Rev Med Pharmacol Sci (2014) 0.78

Lymphotoxin-alpha deficiency completely protects C57BL/6 mice from developing clinical experimental autoimmune myasthenia gravis. J Neuroimmunol (2001) 0.77

Sonoporation of cells for drug and gene delivery. Conf Proc IEEE Eng Med Biol Soc (2004) 0.77

Classification of radar clutter using neural networks. IEEE Trans Neural Netw (1991) 0.77

First identification of Neospora caninum infection in aborted bovine foetuses in China. Vet Parasitol (2007) 0.77

DNA methylation in the regulation of T cell LFA-1 expression. Immunol Invest (2000) 0.76

Irbesartan lowers blood pressure and ameliorates renal injury in experimental non-insulin-dependent diabetes mellitus. Kidney Int Suppl (1997) 0.76